Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers
Genes · 2025
DOI: 10.3390/genes16050556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Jella-Rike J A H Spijkervet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands. Hauptthemen laut MEDLINE: Fanconi Anemia Complementation Group N Protein, Breast Neoplasms, Germ-Line Mutation, Ovarian Neoplasms. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Germline pathogenic variants (GPVs) in PALB2, RAD51C, and RAD51D increase breast cancer (BC) and ovarian cancer (OC) risk. Limited data on clinicopathological characteristics of BC and OC in women with these GPVs hamper guideline development. Therefore, this study aims to describe these characteristics in a consecutive series of female PALB2, RAD51C, and RAD51D GPV carriers.
Methods
Women with a PALB2, RAD51C, or RAD51D GPV determined before July 2023 at the University Medical Center Groningen were included. Cancer diagnoses were obtained through linkage with the Dutch Nationwide Pathology Databank (Palga). Median onset age and histopathological subtypes were compared to the data of The Netherlands Cancer Registry (NCR).
Results
Among 164 GPV carriers (125 PALB2, 30 RAD51C, and 9 RAD51D), 54 BC and 6 OC cases were identified. The median BC onset age was 52 (n = 50), 71 (n = 3), and 43 years (n = 1) for PALB2, RAD51C, and RAD51D, respectively, compared with 62 years in the NCR. No BC histological subtype differences were observed in PALB2 carriers. The populations of RAD51C and RAD51D carriers were too small to compare to NCR data. No OC cases occurred in PALB2 carriers. The median OC onset age was 66 (n = 4) and 56 years (n = 2) for RAD51C and RAD51D carriers, respectively, versus 67 years in the NCR. All RAD51D carriers had high-grade serous carcinoma, compared to 51.5% in the NCR.
Conclusions
Differences in onset age and histological subtypes were observed between GPV carriers and national data. Further research on cancer characteristics is needed to optimize counseling and cancer prevention in these women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
- Department of Genetics, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
- Department of Radiology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
- Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands.
ORCID-Profile: L Lanjouw, L P V Berger, B van der Vegt, G H de Bock
Zitieren
APA
Spijkervet, J. J. A. H., Lanjouw, L., Berger, L. P. V., Dorrius, M. D., van der Vegt, B., & de Bock, G. H. (2025). Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers. Genes. https://doi.org/10.3390/genes16050556
Vancouver
Spijkervet JJAH, Lanjouw L, Berger LPV, Dorrius MD, van der Vegt B, de Bock GH. Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers. Genes. 2025. doi:10.3390/genes16050556
BibTeX
@article{Spijkervet2025,
author = {Spijkervet, Jella-Rike J A H and Lanjouw, L and Berger, L P V and Dorrius, M D and van der Vegt, B and de Bock, G H},
title = {Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16050556}
}
EUVIMED